JP2022507404A5 - - Google Patents
Info
- Publication number
- JP2022507404A5 JP2022507404A5 JP2021526304A JP2021526304A JP2022507404A5 JP 2022507404 A5 JP2022507404 A5 JP 2022507404A5 JP 2021526304 A JP2021526304 A JP 2021526304A JP 2021526304 A JP2021526304 A JP 2021526304A JP 2022507404 A5 JP2022507404 A5 JP 2022507404A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- substituted
- unsubstituted alkyl
- section
- arylalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767180P | 2018-11-14 | 2018-11-14 | |
| US62/767,180 | 2018-11-14 | ||
| PCT/IB2019/001220 WO2020099925A2 (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507404A JP2022507404A (ja) | 2022-01-18 |
| JP2022507404A5 true JP2022507404A5 (enExample) | 2022-11-22 |
| JP7522732B2 JP7522732B2 (ja) | 2024-07-25 |
Family
ID=70732068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526304A Active JP7522732B2 (ja) | 2018-11-14 | 2019-11-14 | 眼疾患治療用のペプチド及び医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3880690A4 (enExample) |
| JP (1) | JP7522732B2 (enExample) |
| KR (1) | KR20210087539A (enExample) |
| CN (1) | CN113474356B (enExample) |
| AU (1) | AU2019378162B2 (enExample) |
| BR (1) | BR112021009341A2 (enExample) |
| MX (1) | MX2021005077A (enExample) |
| SG (1) | SG11202104178TA (enExample) |
| TW (1) | TWI865470B (enExample) |
| WO (1) | WO2020099925A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| KR102662922B1 (ko) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| KR101690539B1 (ko) * | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2822289T3 (es) * | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
-
2019
- 2019-11-13 TW TW108141290A patent/TWI865470B/zh active
- 2019-11-14 SG SG11202104178TA patent/SG11202104178TA/en unknown
- 2019-11-14 WO PCT/IB2019/001220 patent/WO2020099925A2/en not_active Ceased
- 2019-11-14 CN CN201980078779.XA patent/CN113474356B/zh active Active
- 2019-11-14 MX MX2021005077A patent/MX2021005077A/es unknown
- 2019-11-14 BR BR112021009341-9A patent/BR112021009341A2/pt unknown
- 2019-11-14 KR KR1020217018226A patent/KR20210087539A/ko not_active Ceased
- 2019-11-14 JP JP2021526304A patent/JP7522732B2/ja active Active
- 2019-11-14 AU AU2019378162A patent/AU2019378162B2/en active Active
- 2019-11-14 EP EP19883897.1A patent/EP3880690A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020520372A5 (enExample) | ||
| JP7637421B2 (ja) | 新規シクロスポリン誘導体及びその使用 | |
| KR102821964B1 (ko) | 치환된 피롤로피리미딘 jak 억제제 및 이의 제조 및 사용 방법 | |
| RU2019141646A (ru) | Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента | |
| ES2608871T5 (es) | Alafenamide hemifumarate de tenofovir | |
| AU2009268549B2 (en) | Cyclosporin derivatives for treating ocular and dermal diseases and conditions | |
| DE69605282T2 (de) | Synthese von cyclopropylacetylen | |
| JP2022506111A5 (enExample) | ||
| JP2018521092A5 (enExample) | ||
| TW200826938A (en) | Hepatitis C virus inhibitors | |
| TWI865470B (zh) | 治療眼睛疾病之肽及醫藥組合物 | |
| JPH06503092A (ja) | レトロウイルスプロテアーゼ阻害剤 | |
| CA2458699A1 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
| JP2025505200A5 (enExample) | ||
| CN103328497A (zh) | 环孢菌素类似物 | |
| JP2022527556A5 (enExample) | ||
| TW201643178A (zh) | 在ＭｅＢｍｔ側鏈上經雜環修飾之環孢靈素 | |
| JP6742343B2 (ja) | ２環性複素環化合物 | |
| JP2022519924A5 (enExample) | ||
| JPH07607B2 (ja) | レニン阻止剤 | |
| CN105960246A (zh) | 新型环孢菌素衍生物及其用途 | |
| JP2022533991A5 (enExample) | ||
| JP2024510778A5 (enExample) | ||
| RU2021116911A (ru) | Пептиды и фармацевтические композиции для лечения глазных болезней | |
| JP2018536000A (ja) | イソインドリン誘導体 |